dobuject 50 mg ml concentrate for solution for infusion - search results

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

potassium chloride 20% (potassium 27mmol/10ml) solution for infusion 10ml ampoules

potassium 27mmol/10ml) solution for infusion 10ml ampoules (martindale pharmaceuticals ltd - potassium chloride - solution for infusion - 200mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

noradrenaline (base) 2mg/2ml solution for infusion ampoules

base) 2mg/2ml solution for infusion ampoules (pfizer ltd - noradrenaline acid tartrate - solution for infusion - 1mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

stelara 130mg26ml concentrate for solution for infusion vials

janssen-cilag ltd - ustekinumab - solution for infusion - 5mg/1ml

Australia - English - Department of Health (Therapeutic Goods Administration)

rybrevant amivantamab 350 mg/7 ml concentrate for solution for infusion vial

janssen-cilag pty ltd - amivantamab, quantity: 350 mg - injection, concentrated - excipient ingredients: methionine; disodium edetate; histidine; polysorbate 80; histidine hydrochloride monohydrate; water for injections; sucrose - rybrevant has provisional approval for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that has an activating epidermal-growth factor receptor (egfr) exon 20 insertion mutation, whose disease has progressed on or after platinum-based chemotherapy.,the decision to approve this indication has been made on the basis of objective response rate and duration of response in a single arm study. continued approval of this indication depends on verification and description of benefit in a confirmatory study.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

darzalex 100mg5ml concentrate for solution for infusion vials

janssen-cilag ltd - daratumumab - solution for infusion - 20mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

darzalex 400mg20ml concentrate for solution for infusion vials

janssen-cilag ltd - daratumumab - solution for infusion - 20mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

vectibix 100mg5ml concentrate for solution for infusion vials

amgen ltd - panitumumab - solution for infusion - 20mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

vectibix 400mg20ml concentrate for solution for infusion vials

amgen ltd - panitumumab - solution for infusion - 20mg/1ml